Aptinyx Growth, Revenue, Number of Employees and Funding

Overview

Location:
Chicago, IL USA
Total Funding:$237.4M
Industry:Biotech
Founded:2015
Lead Investor(s):Bain Capital Life Sciences
Press

Estimated Revenue & Financials

  • Aptinyx's estimated revenue is currently $6.7M per year.
  • Aptinyx received $70.0M in venture funding in December 2017.
  • Aptinyx's estimated revenue per employee is $103385
  • Aptinyx's total funding is $237.4M.

Employee Data

  • Aptinyx has 65 Employees.
  • Aptinyx grew their employee count by 14% last year.
  • Aptinyx currently has 1 job openings.

What Is Aptinyx?

Welcome to our company page and thank you for your interest in Aptinyx Inc. Aptinyx is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication. Our goal is to rapidly advance our most promising drug candidates into clinical development for indications with high unmet medical need. At Aptinyx, we remain committed and responsive to our employees. We offer an engaging work environment, challenging work assignments, and competitive compensation and benefits. If you are interested in learning more, please visit our website at www.aptinyx.com.

keywords:N/A

65

Number of Employees

$6.7M

Revenue (est)

1

Current Jobs

14%

Employee Growth %

$237.4M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Aptinyx
$6.7M6514%$237.4M
Heidolph North ...
$5.7M4932%
Project Farma
$15M6935%
Tempus
N/A56365%$260M
AveXis
$145.5M848138%$170.5M

Aptinyx News

09/03/2019 - Aptinyx Reports Second Quarter 2019 Financial Results and ...

EVANSTON, Ill., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing ...

09/08/2019 - Aptinyx Inc.'s (APTX) CEO Norbert Riedel on Q2 2019 Results - Earnings Call Transcript

Aptinyx Inc. (NASDAQ:APTX) Q2 2019 Results Earnings Conference Call August 12, 2019 8:00 AM ET. Company Participants. Nick Smith ...

09/03/2019 - Form 8-K Aptinyx Inc. For: Aug 12

On August 12, 2019, Aptinyx Inc., issued a press release announcing its financial results for the quarter ended June 30, 2019. A copy of the ...

Aptinyx Funding

DateAmountRoundLead InvestorsReference
2016-05-10$65.0MANew Leaf Venture PartnersArticle
2017-12-19$70.0MBBain Capital Life SciencesArticle

Aptinyx Executive Hires

DateNameTitleReference
2017-12-08Andy KiddChief commercial officerArticle
2018-02-14Ashish KhannaChief Financial Officer and Chief Business OfficerArticle
2018-05-04David HouckChief Development OfficerArticle